Effects of home-based remote rehabilitation on children and adolescents with cystic fibrosis and non-cystic fibrosis bronchiectasis: a systematic review protocol

Authors

  • Aspasia Mavronasou Clinical Exercise Physiology and Rehabilitation Research Laboratory, Department of Physiotherapy, School of Health Sciences, University of Thessaly, Greece
  • Vaia Sapouna Clinical Exercise Physiology and Rehabilitation Research Laboratory, Department of Physiotherapy, School of Health Sciences, University of Thessaly, Greece https://orcid.org/0000-0002-1935-2538
  • Arietta Spinou School of Life Course and Population Sciences, Faculty of Life Sciences and Medicine, King’s College London, United Kingdom; King’s Centre for Lung Health, King’s College, London, United Kingdom https://orcid.org/0000-0002-3442-4739
  • Konstantinos Douros Pediatric Allergy and Pulmonology Unit, Department of Pediatrics, National and Kapodistrian University of Athens, Greece
  • Eleni A. Kortianou Clinical Exercise Physiology and Rehabilitation Research Laboratory, Department of Physiotherapy, School of Health Sciences, University of Thessaly, Greece https://orcid.org/0000-0003-2214-5545

DOI:

https://doi.org/10.18203/2349-3259.ijct20240655

Keywords:

Adolescents, Bronchiectasis, Children, Cystic fibrosis, Home-based, Remote rehabilitation

Abstract

Background: Home-based remote rehabilitation combining the use of new technological tools is an alternative way of rehabilitation when traditional center-based programs are limited or are not feasible. This systematic review aims to investigate the level of evidence for the effects of home-based remote rehabilitation on children and adolescents with cystic fibrosis (CF) and non-cystic fibrosis bronchiectasis (NCFB).

Methods: This systematic review will follow the preferred reporting items for systematic reviews and meta-analysis (PRISMA). Five databases will be searched from the period of the inception until March 2024: PubMed, Web of Science, Medline (via EBSCOhost), ACM Digital Library, and Scopus. Methodological quality will be assessed using the revised Cochrane Risk of Bias tool for randomized trials (RoB 2) and the risk of bias in non-randomized studies – of interventions (ROBINS-1) tool. The overall quality of the evidence will be assessed using the grading of recommendations assessment, development, and evaluation (GRADE) approach.

Conclusions: Evaluation of the level of evidence for the effects of home-based remote rehabilitation in children and adolescents with CF and NCFB is an important step in the context of telehealth, providing an alternative way of approaching pediatric patients, during the process of rehabilitation.

Trial registration: PROSPERO registration number is CRD42024498403.

References

Goyal V, Chang AB. Bronchiectasis in Childhood. Clin Chest Med. 2022;43(1):71-88.

Gokdemir Y, Hamzah A, Erdem E, Cimsit C, Ersu R, Karakoc F, et al. Quality of life in children with non-cystic-fibrosis bronchiectasis. Respiration. 2014;88(1):46-51.

Spinou A, Fragkos KC, Lee KK, Elston C, Siegert RJ, Loebinger MR, et al. The validity of health-related quality of life questionnaires in bronchiectasis: a systematic review and meta-analysis. Thorax. 2016;71(8):683-94.

Kapur N, Masters IB, Chang AB. Longitudinal growth and lung function in pediatric non-cystic fibrosis bronchiectasis: what influences lung function stability. Chest. 2010;138(1):158-64.

Kapur N, Masters IB, Newcombe P, Chang AB. The burden of disease in pediatric non-fibrosis bronchiectasis. Chest. 2012;141(4):1018-24.

Lovie-Toon YG, Grimwood K, Byrnes CA, Goyal V, Busch G, Masters IB, et al. Health-resource use and quality of life in children with bronchiectasis: a multi-center pilot cohort study. BMC Health Service Res. 2019;19(1):561.

Poeta M, Maglione M, Borrelli M, Santamaria F. Non-cystic fibrosis bronchiectasis in children and adolescents: Neglected and emerging issues. Pediatrics Neonat. 2020;61(3):255-62.

Junior MGDN, Xavier DM, Abreu RAL, da Silva LF, de Miranda JP, Aquino MJDV, et al. Home-Based Rehabilitation in Children and Adolescents with Cystic Fibrosis: A Systematic Review with Meta-Analysis and Grade Recommendations. Physical Occup Therapy Pediatrics. 2023;43(5):528-47.

Kodjebacheva GD, Tang C, Groesbeck F, Walker L, Woodworth J, Schindler-Ruwisch J. Telehealth Use in Pediatric Care during the COVID-19 Pandemic: A Qualitative Study on the Perspectives of Caregivers. Children. 2023;10(2):311.

Faical AVB, Mota LR, Correia DA, Monteiro LP, de Souza EL, Terse-Ramos R. Telehealth for children and adolescents with chronic pulmonary disease: systematic review. Revista Paulista de Pediatria. 2023;42:e2024111.

Fainardi V, Capoferri G, Tornesello M, Pisi G, Esposito S. Telemedicine and Its Application in Cystic Fibrosis. J Personalized Med. 2023;13(7):1041.

Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Rev. 2015;4(1):1.

Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. Br Med J. 2015;350:7647.

Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. Br Med J. 2021;372:160.

Harrison H, Griffin SJ, Kuhn I, Usher-Smith JA. Software tools to support title and abstract screening for systematic reviews in healthcare: an evaluation. BMC Med Res Methodolol. 2020;20(1):7.

Sterne JAC, Savovic J, Page MJ, Elbers RG, Blencowe NS, Boutron J, et al. RoB 2: a revised tool for assessing risk of bias in randomized trials. Br Med J. 2019;366:4898.

Sterne JAC, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomized studies of interventions. Br Med J. 2016;355:4919.

Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401-6.

Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Br Med J. 2008;336(7650):924-46.

Karatas N, Kaya A, Dalgic AI. The effectiveness of user-focused mobile health applications in paediatric chronic disease management: A systematic review. J Pediatric Nurs. 2022;63:e149-56.

Chang AB, Boyd J, Bush A, Hill AT, Powell Z, Zacharasiewicz A, et al. Quality standards for managing children and adolescents with bronchiectasis: an international consensus. Breath (Sheff). 2022;18(3):220144.

Downloads

Published

2024-03-01